Literature DB >> 33753927

Hovlinc is a recently evolved class of ribozyme found in human lncRNA.

Yue Chen1, Fei Qi2, Fan Gao1, Huifen Cao1, Dongyang Xu1, Kourosh Salehi-Ashtiani3, Philipp Kapranov4.   

Abstract

Although naturally occurring catalytic RNA molecules-ribozymes-have attracted a great deal of research interest, very few have been identified in humans. Here, we developed a genome-wide approach to discovering self-cleaving ribozymes and identified a naturally occurring ribozyme in humans. The secondary structure and biochemical properties of this ribozyme indicate that it belongs to an unidentified class of small, self-cleaving ribozymes. The sequence of the ribozyme exhibits a clear evolutionary path, from its appearance between ~130 and ~65 million years ago (Ma), to acquiring self-cleavage activity very recently, ~13-10 Ma, in the common ancestors of humans, chimpanzees and gorillas. The ribozyme appears to be functional in vivo and is embedded within a long noncoding RNA belonging to a class of very long intergenic noncoding RNAs. The presence of a catalytic RNA enzyme in lncRNA creates the possibility that these transcripts could function by carrying catalytic RNA domains.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33753927     DOI: 10.1038/s41589-021-00763-0

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  47 in total

1.  The structural basis of ribosome activity in peptide bond synthesis.

Authors:  P Nissen; J Hansen; N Ban; P B Moore; T A Steitz
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

Review 2.  Chemistry and Biology of Self-Cleaving Ribozymes.

Authors:  Randi M Jimenez; Julio A Polanco; Andrej Lupták
Journal:  Trends Biochem Sci       Date:  2015-10-15       Impact factor: 13.807

3.  Functional nucleic-acid-based sensors for environmental monitoring.

Authors:  Arghya Sett; Suradip Das; Utpal Bora
Journal:  Appl Biochem Biotechnol       Date:  2014-06-06       Impact factor: 2.926

4.  The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme.

Authors:  C Guerrier-Takada; K Gardiner; T Marsh; N Pace; S Altman
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene.

Authors:  Kourosh Salehi-Ashtiani; Andrej Lupták; Alexander Litovchick; Jack W Szostak
Journal:  Science       Date:  2006-09-22       Impact factor: 47.728

6.  Intronic hammerhead ribozymes are ultraconserved in the human genome.

Authors:  Marcos de la Peña; Inmaculada García-Robles
Journal:  EMBO Rep       Date:  2010-07-23       Impact factor: 8.807

7.  Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena.

Authors:  K Kruger; P J Grabowski; A J Zaug; J Sands; D E Gottschling; T R Cech
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

Review 8.  Therapeutic applications of group I intron-based trans-splicing ribozymes.

Authors:  Chang Ho Lee; Seung Ryul Han; Seong-Wook Lee
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-01-31       Impact factor: 9.957

9.  Twister ribozymes as highly versatile expression platforms for artificial riboswitches.

Authors:  Michele Felletti; Julia Stifel; Lena A Wurmthaler; Sophie Geiger; Jörg S Hartig
Journal:  Nat Commun       Date:  2016-09-27       Impact factor: 14.919

10.  Novel ribozymes: discovery, catalytic mechanisms, and the quest to understand biological function.

Authors:  Christina E Weinberg; Zasha Weinberg; Christian Hammann
Journal:  Nucleic Acids Res       Date:  2019-10-10       Impact factor: 16.971

View more
  1 in total

1.  cyPhyRNA-seq: a genome-scale RNA-seq method to detect active self-cleaving ribozymes by capturing RNAs with 2',3' cyclic phosphates and 5' hydroxyl ends.

Authors:  V Janett Olzog; Christiane Gärtner; Peter F Stadler; Jörg Fallmann; Christina E Weinberg
Journal:  RNA Biol       Date:  2021-12-14       Impact factor: 4.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.